文献速递生殖医学

「立即IVF」与「延迟IVF」的成本效果比较:一项前瞻性研究

Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study.
PubMed 文献 · Hum Reprod · 2017-01-01

基于荷兰2002年1月至2003年12月国家等待名单中5962对符合IVF或ICSI指征夫妇的建模研究,比较立即IVF与推迟1年IVF的成本效果。立即IVF每增加一例活产的成本效果比在不明原因不孕夫妇中最高(15000至超过60000欧元),并强烈取决于女性年龄和不孕持续时间;子宫内膜异位症夫妇最低(8000至23000欧元)。

要点

  • 立即IVF较延迟IVF的活产率增益随女性年龄增加,与诊断类别或不孕持续时间无关。
  • 成本效果比在子宫内膜异位症中最低(8000至23000欧元),在不明原因不孕中最高(15000至超过60000欧元)。
  • 不明原因不孕夫妇在30岁、不孕3年时成本效果比达56000欧元/活产,32岁起降至30000欧元/活产以下。

核心结论

  • IVF具有成本效果的不孕持续时间首先取决于社会对每增加一例活产的支付意愿水平,其次在给定支付意愿下取决于女性年龄和诊断类别。
  • 当前指南在决定是否开始IVF治疗及何时开始时,应始终考虑自然受孕的机会。

研究设计与样本

  • 采用建模方法,基于文献和一项前瞻性队列研究数据,该队列为2002年1月至2003年12月期间在荷兰国家等待名单中登记的符合IVF或ICSI治疗条件的夫妇。
  • 共纳入5962对夫妇;自然持续妊娠几率从等待名单观察中估计,IVF后持续妊娠几率从开始治疗的原发不孕夫妇随访数据中估计。
  • 考虑预后特征为女性年龄、不孕持续时间和诊断类别;IVF成本从社会角度评估并在代表性患者样本中确定。
  • 比较两种情景:(I)再等待一年后接受1年IVF;(II)立即IVF持续1年,并在随后一年尝试自然受孕;比较按预后因素分层进行,最终结局为活产。

主要发现

  • 立即IVF情景较推迟IVF的活产率增益随女性年龄增加,且与诊断类别或不孕持续时间无关。
  • 相应的成本增加主要取决于诊断类别和不孕持续时间。
  • 最低成本效果比略低于每活产10000欧元,见于子宫内膜异位症、34岁及以上、不孕持续时间1年。
  • 最高成本效果比达每活产56000欧元,见于不明原因不孕、30岁、不孕持续时间3年;32岁起降至每活产30000欧元以下,34岁及以上且不孕3年时降至每活产20000欧元以下。
  • 其他三个诊断类别(即男性因素、激素因素和免疫/宫颈因素)的成本效果比介于上述两者之间。

关键数值与推荐

  • 成本效果比为立即IVF与延迟IVF相比每额外活产的增量成本。
  • 子宫内膜异位症的成本效果比范围为8000至23000欧元。
  • 不明原因不孕的成本效果比范围为15000至超过60000欧元。

临床怎么用

  • 作者认为,当前指南在决定是否开始IVF治疗及何时开始时,应始终考虑自然受孕的机会。
  • 原文未据此给出其他推荐。

局限性

  • 研究应用了IVF成功几率的估计值,排除了冻融胚胎,因无相关数据。
  • 因此,研究不知道冻融胚胎移植对成本效果的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How does the cost-effectiveness (CE) of immediate IVF compared with postponing IVF for 1 year, depend on prognostic characteristics of the couple? SUMMARY ANSWER: The CE ratio, i.e. the incremental costs of immediate versus delayed IVF per extra live birth, is the highest (range of €15 000 to >€60 000) for couples with unexplained infertility and for them depends strongly on female age and the duration of infertility, whilst being lowest for endometriosis (range 8000-23 000) and, for such patients, only slightly dependent on female age and duration of infertility. WHAT IS KNOWN ALREADY: A few countries have guidelines for indications of IVF, using the diagnostic category, female age and duration of infertility. The CE of these guidelines is unknown and the evidence base exists only for bilateral tubal occlusion, not for the other diagnostic categories. STUDY DESIGN, SIZE, DURATION: A modelling approach was applied, based on the literature and data from a prospective cohort study among couples eligible for IVF or ICSI treatment, registered in a national waiting list in The Netherlands between January 2002 and December 2003. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 5962 couples was included. Chances of natural ongoing pregnancy were estimated from the waiting list observations and chances of ongoing pregnancy after IVF from follow-up data of couples with primary infertility that began treatment. Prognostic characteristics considered were female age, duration of infertility and diagnostic category. Costs of IVF were assessed from a societal perspective and determined on a representative sample of patients. A cost-effectiveness comparison was made between two scenarios: (I) wait one more year and then undergo IVF for 1 year and (II) immediate IVF during 1 year, and try to conceive naturally in the following year. Comparisons were made for strata determined by the prognostic factors. The final outcome was a live birth. MAIN RESULTS AND THE ROLE OF CHANCE: The gain in live birth rate of the immediate IVF scenario versus postponed IVF increased with female age, and was independent from diagnostic category or duration of infertility. By contrast, the corresponding increase in costs primarily depended on diagnostic category and duration of infertility. The lowest CE ratio was just below €10 000 per live birth for endometriosis from age 34 onwards at 1 year duration. The highest CE ratio reached €56 000 per live birth for unexplained infertility at age 30 and 3 years duration, dropping to values below € 30 000 per live birth from age 32 onwards. It reached values below €20 000 per live birth with 3 years duration at age 34 and older. The CE ratio was in between for the three other diagnostic categories (i.e. Male infertility, Hormonal and Immunological/Cervical). LIMITATIONS, REASONS FOR CAUTION: We applied estimates of chances with IVF, excluding frozen embryos, for which we had no data. Therefore, we do not know the effect of frozen embryo transfers on the CE. WIDER IMPLICATIONS OF THE FINDINGS: The duration of infertility at which IVF becomes cost-effective depends, firstly, on the level of society's willingness to pay for one extra live birth, and secondly, given a certain level of willingness to pay, on the woman's age and the diagnostic category. In current guidelines, the chances of a natural conception should always be taken into account before deciding whether to start IVF treatment and at which time. STUDY FUNDING/COMPETING INTEREST(S): Supported by Netherlands Organisation for Health Research and Development (ZonMW, grant 945-12-013). ZonMW had no role in designing the study, data collection, analysis and interpretation of data or writing of the report. Competing interests: none.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Eijkemans MJC, Kersten FAM, Lintsen AME, et al. Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study. Hum Reprod. 2017. PMID: 28204519. doi:10.1093/humrep/dex018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。